Credit: Cell (2024). DOI: 10.1016/j.cell.2024.04.015 By examining the immune modulations of tumors during the day, scientists from the University of Geneva and the LMU Munich are demonstrating their impact on the diagnosis and management of patients. The currently most promising anti-tumor treatments are immunotherapies, which aim to boost the action of the patients’ immune system to fight cancer. However, while these treatments are highly effective in some cases, their success is sometimes disappointing. How can this variability be explained? In previous studies, a team from the University of Geneva (UNIGE) Read More
